Cargando…

M7. LOWER THALAMIC DOPAMINE D2-RECEPTOR BINDING IN DRUG-NAIVE PATIENTS WITH PSYCHOSIS – A REPLICATION STUDY USING POSITRON EMISSION TOMOGRAPHY

BACKGROUND: The dopamine system is a central focus of research on the pathophysiology and treatment of schizophrenia. With regard to the dopamine D2-receptor (D2-R), Positron Emission Tomography (PET) studies have shown a small increase in striatal receptor availability. In contrast, a more recent l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Victorsson, Pauliina, Plavén-Sigray, Pontus, Matheson, Granville, Santillo, Alexander, Lee, Maria, Collste, Karin, Fatouros-Bergman, Helena, Agartz, Ingrid, Halldin, Christer, Farde, Lars, Cervenka, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session II
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233970/ http://dx.doi.org/10.1093/schbul/sbaa030.319

Ejemplares similares

Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis
por: Plavén-Sigray, Pontus, et al.
Publicado: (2021)

No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosis
por: Lee, Maria, et al.
Publicado: (2021)

Is dopamine D1 receptor availability related to social behavior? A positron emission tomography replication study
por: Plavén-Sigray, Pontus, et al.
Publicado: (2018)

[(11)C]SCH23390 binding to the D(1)-dopamine receptor in the human brain—a comparison of manual and automated methods for image analysis
por: Stenkrona, Per, et al.
Publicado: (2018)

D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients
por: Stenkrona, Per, et al.
Publicado: (2019)

Test-retest reliability and convergent validity of (R)-[(11)C]PK11195 outcome measures without arterial input function
por: Plavén-Sigray, Pontus, et al.
Publicado: (2018)

Assessment of simplified ratio-based approaches for quantification of PET [(11)C]PBR28 data
por: Matheson, Granville J., et al.
Publicado: (2017)

Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data
por: Plavén-Sigray, Pontus, et al.
Publicado: (2018)

Clinical brain PET research must embrace multi-centre collaboration and data sharing or risk its demise
por: Matheson, Granville James, et al.
Publicado: (2019)

Meta-analytic studies of the glial cell marker TSPO in psychosis – a question of apples and pears?: A commentary on ‘Neuroinflammation in schizophrenia: metaanalysis of in-vivo microglial imaging’ by Marques et al.
por: Plavén-Sigray, P., et al.
Publicado: (2019)

CSF GABA is reduced in first-episode psychosis and associates to symptom severity
por: Orhan, F, et al.
Publicado: (2018)

The readability of scientific texts is decreasing over time
por: Plavén-Sigray, Pontus, et al.
Publicado: (2017)

Trait impulsivity is not related to post-commissural putamen volumes: A replication study in healthy men
por: Caravaggio, Fernando, et al.
Publicado: (2018)

T7. UPDATED INDIVIDUAL PARTICIPANT DATA META-ANALYSIS CONFIRMS LOWER LEVELS OF THE GLIAL MARKER TSPO IN PSYCHOSIS PATIENTS
por: Plavén-Sigray, Pontus, et al.
Publicado: (2020)

In vivo correlation of serotonin transporter and 1B receptor availability in the human brain: a PET study
por: Svensson, Jonas E., et al.
Publicado: (2022)

Serotonin transporter availability increases in patients recovering from a depressive episode
por: Svensson, Jonas E., et al.
Publicado: (2021)

Effects of amphetamine on the human brain opioid system – a positron emission tomography study
por: Guterstam, Joar, et al.
Publicado: (2013)

Associations Between Cognition and Serotonin 1B Receptor Availability in Healthy Volunteers: A [(11)C]AZ10419369 Positron Emission Tomography Study
por: Tangen, Ämma, et al.
Publicado: (2022)

Kinfitr — an open-source tool for reproducible PET modelling: validation and evaluation of test-retest reliability
por: Tjerkaski, Jonathan, et al.
Publicado: (2020)

Serotonin 5-HT(1A) receptor binding and self-transcendence in healthy control subjects—a replication study using Bayesian hypothesis testing
por: Griffioen, Gina, et al.
Publicado: (2018)

M169. HIPPOCAMPAL GLUTAMATE AND HIPPOCAMPUS SUBFIELD VOLUMES IN ANTIPSYCHOTIC-NAIVE FIRST EPISODE PSYCHOSIS SUBJECTS AND RELATIONSHIPS TO DURATION OF UNTREATED PSYCHOSIS
Publicado: (2020)

Serotonin transporter availability in adults with autism—a positron emission tomography study
por: Andersson, Max, et al.
Publicado: (2020)

Reliability of dopamine transporter PET measurements with [(18)F]FE-PE2I in patients with Parkinson’s disease
por: Kerstens, Vera S., et al.
Publicado: (2020)

Decreased 5‐HT(1A) binding in mild Alzheimer's disease—A positron emission tomography study
por: Mattsson, Patrik, et al.
Publicado: (2022)

CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects
por: Xu, Chengai, et al.
Publicado: (2020)

Simulations to benchmark time-varying connectivity methods for fMRI
por: Thompson, William Hedley, et al.
Publicado: (2018)

Plasma bilirubin levels are reduced in first-episode psychosis patients and associates to working memory and duration of untreated psychosis
por: Becklén, Meneca, et al.
Publicado: (2021)

Thinking Outside a Less Intact Box: Thalamic Dopamine D2 Receptor Densities Are Negatively Related to Psychometric Creativity in Healthy Individuals
por: de Manzano, Örjan, et al.
Publicado: (2010)

Early stopping in clinical PET studies: How to reduce expense and exposure
por: Svensson, Jonas E, et al.
Publicado: (2021)

An in vivo Pig Model for Testing Novel Positron Emission Tomography Radioligands Targeting Cerebral Protein Aggregates
por: Raval, Nakul Ravi, et al.
Publicado: (2022)

M143. REGIONAL CEREBRAL BLOOD FLOW IN INITIALLY ANTIPSYCHOTIC-NAïVE PATIENTS WITH SCHIZOPHRENIA OR PSYCHOSIS: EFFECTS OF PARTIAL D2 RECEPTOR AGONISM AND ASSOCIATION WITH SYMPTOM IMPROVEMENT
por: Bojesen, Kirsten, et al.
Publicado: (2020)

PET Evaluation of the Novel F-18 Labeled Reversible Radioligand [(18)F]GEH200449 for Detection of Monoamine Oxidase-B in the Non-Human Primate Brain
por: Varnäs, Katarina, et al.
Publicado: (2023)

Facial affect recognition in first-episode psychosis is impaired but not associated with psychotic symptoms()
por: Larsson, Cornelia, et al.
Publicado: (2022)

M195. LATENT STRUCTURE OF NEGATIVE SYMPTOMS IN EARLY PSYCHOSIS AND CLINICAL HIGH-RISK FOR PSYCHOSIS
por: Chi Yiu Wong, Sandra, et al.
Publicado: (2020)

Detection of amyloid in Alzheimer’s disease with positron emission tomography using [(11)C]AZD2184
por: Nyberg, Svante, et al.
Publicado: (2009)

M118. FACTOR STRUCTURE OF THE CLINICIAN-RATED DIMENSION OF PSYCHOSIS SYMPTOM SEVERITY IN PATIENTS WITH EARLY PSYCHOSIS
por: Lee, Kyuyoung, et al.
Publicado: (2020)

Effects of age, BMI and sex on the glial cell marker TSPO — a multicentre [(11)C]PBR28 HRRT PET study
por: Tuisku, Jouni, et al.
Publicado: (2019)

M22. IGG ANTIBODIES TO TOXOPLASMA GONDII ARE ASSOCIATED WITH INCREASED LONG-TERM RISK FOR PSYCHOSIS IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS
por: Berger, Maximus, et al.
Publicado: (2020)

Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder
por: Lundberg, Johan, et al.
Publicado: (2012)

M98. IS THERE A DEVELOPMENTAL TRAUMAGENIC PHENOTYPE OF PSYCHOSIS?
por: Bloomfield, Michael, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aot58rebeirjot922qkuql2ev0